Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance or update; the study information shown remains unchanged.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- The page now shows a new revision label (v3.5.3), replacing the previous v3.5.2. This indicates a minor update to the document.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSite software version updated from v3.5.0 to v3.5.2. No user-facing changes to study content or page structure are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new frontend revision label: Revision: v3.5.0, and removed the previous Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label in the site footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page shows a site revision: 'Revision: v3.4.2' is listed, with a prior entry for v3.4.1 and a legacy government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.